MYRIAD GENETICS, INC. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
MYRIAD GENETICS, INC. (MYGN) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $175.63 million as of 2015-03-31, per its 10-Q filed 2015-05-06.
Discontinued › Notes › Investments › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2015-05-06
- 2015-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $175.63M.
- 2014-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $229.55M.
- 2014-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $236.36M.
- 2014-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $270.59M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2015-03-31 | $175.63M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $229.55M 10-Q · filed 2015-02-04 |
| 2014-09-30 | $236.36M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $270.59M 10-K · filed 2014-08-13 |
| 2014-03-31 | $277.71M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $488.78M 10-Q · filed 2014-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |